Asian Pacific Journal of Allergy and Immunology

  • HOME
  • ABOUT
  • EDITORS
  • SUBMISSION
    • Online Submission
    • Author Instructions
  • ISSUE
    • Current
    • Early Online
    • Archives
  • PERMISSIONS
  • CONTACT
  • ADVERTISE
Home
 / 
Original Article
 / 
Original Article
 / 
Page 13
March 15, 2021

A prospective cohort study of cord blood 25(OH)D3 and food allergies in 6-month-old Chinese infants

Vitamin D is closely related to childhood allergic diseases, such as food allergies, atopic dermatitis, and asthma. However, it is unclear whether vitamin D status in the cord blood from mothers is related to food allergies in infants.
read more
25(OH)D3, Cord blood, food allergies, gestation, infant
March 15, 2021

Threshold dose of cow’s milk in sensitization to casein higher than those of casein and β-lactoglobulin in children with cow’s milk allergy

Recent treatment for food allergies involves the intake of allergy-causing foods at doses lower than the threshold dose determined by the oral food challenge (OFC). For a more successful treatment, it is necessary to identify a biomarker to establish safer doses of allergens in foods consumed at home.
read more
Casein, Cow’s milk, food allergy, Oral Food Challenge, Sensitization, β-lactoglobulin
January 30, 2021

Twelve-month growth and accession of tolerance in infants with cow’s milk protein allergy compared among those fed with breast milk or alternative formulae

Cow’s milk protein allergy (CMPA) is a common food allergy in children. The impact of various feeding regimens on growth in infants with CMPA is not sufficiently well understood.
read more
accession of tolerance, alternative formulae, breast milk, cow’s milk protein allergy, infants, Twelve-month growth
January 30, 2021

Successful treatment of neurocysticercosis with albendazole desensitization

Neurocysticercosis is a growing public health problem in the United States. Albendazole is a mainstay of medical therapy for neurocysticercosis, and here we present a case of hypersensitivity to albendazole leading to life-threatening disease progression.
read more
Adverse drug reaction, Albendazole, Anti-parasite, Desensitization, Drug hypersensitivity, Neurocysticercosis, Orally
January 30, 2021

Anxiety and depression in allergic rhinitis patients during COVID-19 pandemic in Wuhan, China

During COVID-19 pandemic, many allergic rhinitis (AR) patients stopped their treatment including pharmacotherapy and allergen immunotherapy.
read more
Allergic rhinitis, anxiety, COVID-19, depression, VAS
January 30, 2021

CD28 confers CD4+ T cells with resistance to cyclosporin A and tacrolimus but to different degrees

Cyclosporin A (CSA) and tacrolimus (TAC) suppress T-cell activation and subsequent proliferation by inhibiting calcineurin. Though they have the same target, CSA and TAC have quite different molecular structures, indicating quantitative and/or qualitative differences in their effects.
read more
Calcineurin inhibitor, CD28, Cyclosporin A, T-cell activation, Tacrolimus
January 30, 2021

Efficacy of drug therapies in antihistamine refractory chronic spontaneous urticaria: Real life data

Omalizumab is a safe and effective treatment for antihistamine-refractory chronic spontaneous urticaria (CSU) but is insufficient in one-third of patients. For serious cases in which omalizumab is ineffective, cyclosporine or methotrexate may be preferred. Most drug trials in CSU have focused on omalizumab or cyclosporine monotherapy.
read more
chronic spontaneous urticaria, cyclosporine, efficacy, methotrexate, Omalizumab, safety, treatment
January 30, 2021

Depression scores change significantly after omalizumab treatment in patients with chronic spontaneous urticaria

Chronic spontaneous urticaria (CSU) is frequently associated with psychiatric comorbidities.
read more
biomarker, depression, Omalizumab, psychiatric comorbidity, urticaria
January 30, 2021

Effect of fexofenadine/pseudoephedrine combination tablet on nasal obstruction in patients with allergic rhinitis using rhinomanometry: A randomized controlled trial

A fexofenadine/pseudoephedrine combination tablet (F/P) is an optimal product for nasal obstruction. It contains fexofenadine hydrochloride, a histamine H1-receptor antagonist for sneezing and rhinorrhea and pseudoephedrine hydrochloride, an α-adrenergic agonist. The effect of an antihistamine-decongestant on nasal obstruction has been demonstrated in previous studies, but onset of action and efficacy data on nasal obstruction are limited.
read more
Allergic rhinitis, Antihistamine, Nasal obstruction, Rhinomanometry, Visual analog scale
January 4, 2021

Allergic contact dermatitis to topical medicaments: Revisited

Allergic reaction to topical drugs varies depending on use and availability of topical drugs and self-medication.
read more
allergic contact dermatitis, contact sensitization, contributing factors, patch test, topical medicaments

Pages:

« 1 … 11 12 13 14 15 … 23 »

Categories

  • Announcement (1)
  • Case Report (23)
  • Early Online (97)
  • Original Article (227)
  • Review Article (29)

Key words

allergen Allergic rhinitis Allergy Anaphylaxis Asthma atopic dermatitis child Children chronic rhinosinusitis chronic spontaneous urticaria Chronic Urticaria COVID-19 COVID-19 vaccine cytokine depression diagnosis drug allergy Drug hypersensitivity efficacy Epidemiology food allergy Food hypersensitivity house dust mite IgE Immunotherapy obstructive sleep apnea Omalizumab prevalence primary immunodeficiency Quality of life Questionnaire Reliability risk factor risk factors safety SARS-CoV-2 Sensitization Severe asthma Skin prick test Specific IgE Thai treatment urticaria vaccine Vitamin D
Asian Pacific Journal of Allergy and Immunology

Support Contact

Managing Editor
Ms. Patrawadee Pitakpolrat
E-mail: managingeditor@apjai-journal.org

Production Editor
Ms. Chanita Jangsawang
E-mail: chanita.j@apjai-journal.org

Asian Pacific Journal of Allergy and Immunology © 2026 All rights reserved.
All rights reserved | Privacy Policy